Today: 24 November 2025
Subscribe
Browse Tag

Stock Analysis

Microsoft Stock Today (MSFT) – November 24, 2025: Anthropic’s $30 Billion Azure Deal, New AI Tie‑Ups and Fresh Analyst Targets

Microsoft Stock Today (MSFT) – November 24, 2025: Anthropic’s $30 Billion Azure Deal, New AI Tie‑Ups and Fresh Analyst Targets

Microsoft Corporation (NASDAQ: MSFT) is edging higher today as Wall Street digests a flood of new AI‑related deals, analyst calls and sustainability news that reinforce the long‑term growth story—even as the stock is still nursing a double‑digit pullback since earnings.
24 November 2025
 ·  ·  ·  ·  · 
Recursion Pharmaceuticals (RXRX) Stock Today: ‘Hold’ Rating, New Institutional Buying and AI Drug Discovery Hype — November 23, 2025

Recursion Pharmaceuticals (RXRX) Stock Today: ‘Hold’ Rating, New Institutional Buying and AI Drug Discovery Hype — November 23, 2025

Snapshot: Where RXRX Stands Going Into the New Week Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) closed Friday, November 21, 2025, at $4.17, up 8.31% on the day after bouncing off the low‑$3 range earlier in the week. Volume was heavy at
24 November 2025
 ·  ·  ·  · 
Marvell Technology (MRVL) Stock on November 23, 2025: Raymond James “Strong Buy” vs. Valuation Jitters Before Key AI Earnings

Marvell Technology (MRVL) Stock on November 23, 2025: Raymond James “Strong Buy” vs. Valuation Jitters Before Key AI Earnings

Published: November 23, 2025 Marvell Technology’s stock heads into the new trading week with a fresh “strong buy” call from Wall Street, major institutional investors reshuffling their positions, and a growing debate over whether the AI-fueled chipmaker is now overvalued
24 November 2025
 ·  ·  ·  · 
1 2 3 … 10
Go toTop